Literature DB >> 18362474

Granule formation in NGF-cultured mast cells is associated with expressions of pyruvate kinase type M2 and annexin I proteins.

Ji Young Kim1, Dae Yong Kim, Jai Youl Ro.   

Abstract

BACKGROUND: Nerve growth factor (NGF) is a potent mediator, which regulates characteristics of mast cells, but its biological function is not well characterized. This study aimed to screen proteins associated with the maturation of human mast cells-1 (HMC-1) or mouse bone marrow-derived mast cells (BMMCs) cultured with NGF, and to examine the functions of proteins involved.
METHODS: NGF (10 ng/ml) was added to cell culture medium every other day for 10 days for HMC-1 or twice a week for 5 weeks for BMMCs. Granule formation was determined by electron microscopy or May-Grunwald-Giemsa staining, TNF-alpha by ELISA, expressions of various proteins by two-dimensional gel electrophoresis (2-DE), siRNA transfection by Lipofectamine 2000, and the expressions of pyruvate kinase and annexin I by immunoblotting.
RESULTS: After NGF treatment, granule formation and total amounts of granular mediator, TNF-alpha increased in both mast cells. This TNF-alpha was released by calcium ionophore or by antigen/antibody reaction. Expressions of pyruvate kinase and annexin I obtained by 2-DE were confirmed by immunoblotting and siRNA-transfected HMC-1 cells. Expressions of proteins, granule formation and TNF-alpha content were blocked by both the TrkA inhibitor, K252a, and the ERK inhibitor, PD98059, but not by the PI3 kinase inhibitors, LY294002 and wortmannin.
CONCLUSION: These data suggest that pyruvate kinase and annexin I expressed by NGF contribute to granule formation containing TNF-alpha as well as other mediators in mast cells, which play a major role in allergic diseases via a TrkA/ERK pathway. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362474     DOI: 10.1159/000121463

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

Review 1.  Human pyruvate kinase M2: a multifunctional protein.

Authors:  Vibhor Gupta; Rameshwar N K Bamezai
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture.

Authors:  Eva Bernhart; Manfred Kollroser; Gerald Rechberger; Helga Reicher; Akos Heinemann; Petra Schratl; Seth Hallström; Andrea Wintersperger; Christoph Nusshold; Trevor DeVaney; Klaus Zorn-Pauly; Roland Malli; Wolfgang Graier; Ernst Malle; Wolfgang Sattler
Journal:  Proteomics       Date:  2010-01       Impact factor: 3.984

3.  Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells.

Authors:  Dae Yong Kim; Eun Young Kwon; Gwan Ui Hong; Yun Song Lee; Seung-Hyo Lee; Jai Youl Ro
Journal:  Respir Res       Date:  2011-04-18

4.  Polyamines are present in mast cell secretory granules and are important for granule homeostasis.

Authors:  Gianni García-Faroldi; Carlos E Rodríguez; José L Urdiales; José M Pérez-Pomares; José C Dávila; Gunnar Pejler; Francisca Sánchez-Jiménez; Ignacio Fajardo
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  20(S)-Protopanaxatriol inhibits release of inflammatory mediators in immunoglobulin E-mediated mast cell activation.

Authors:  Dae Yong Kim; Jai Youl Ro; Chang Ho Lee
Journal:  J Ginseng Res       Date:  2014-11-24       Impact factor: 6.060

Review 6.  Research progress on the role of PKM2 in the immune response.

Authors:  Chunyan Liu; Chenchen Liu; Rong Fu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

7.  Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions.

Authors:  Ajantha Sinniah; Samia Yazid; Stefania Bena; Sonia M Oliani; Mauro Perretti; Rod J Flower
Journal:  Front Pharmacol       Date:  2019-11-13       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.